Furthermore, Schedule III could mean that independent researchers—not just pharma shills—might finally get a seat at the table. Universities won’t have to fear losing their funding just for touching the plant. We might see a new wave of “less biased” research that explores the nuances of the entourage effect or minor cannabinoids like THCV or CBG, rather than just focusing on how much “reefer madness” can be induced in a lab rat.
A first-person review of the hemp-derived THC cocktail base I poured at our Cannabis Cup…
Every paper mill in the world still runs on the continuous-web design a Frenchman patented…
A new AI-assisted sci-fi satire from filmmaker Dan Levy Dagerman and the Space Weed Universe…
Spain has increased penalties for electricity theft linked to indoor cannabis cultivation after Endesa reported…
How a 52-year-old first-time grower turned trial and error into a show-stopping harvest The first…
This is the legacy knowledge drain, and it is the quiet catastrophe nobody in the…